Opportunities in the C5 inhibitors market include developing next-gen biosimilars and biosuperiors to improve administration frequency and expand treatment indications for diseases like aHUS, SCD, MG, ...
12don MSN
Rallybio shares successful early-stage results for rare disease drug; new trial set for late 2026
Rallybio Corporation RLYB on Tuesday shared results from its Phase 1 confirmatory pharmacokinetic/pharmacodynamic (PK/PD) ...
"Monogenic" diseases, triggered by mutations in just one gene, may actually be more complex than scientists thought.
Lifestyle diseases such as high cholesterol, liver disorders, diabetes, and other metabolic conditions are rising rapidly across the world. Swami Ramdev explains how yoga, pranayama, disciplined ...
Leerink Partners Global Healthcare Conference March 8 - 11, 2026 in Miami, FL Fireside chat on March 9 at 9:20 AM ET InflaRx will also conduct one-on-one investor meetings on March 9th. A link to view ...
A privacy-first AI can diagnose a life-shortening hormone disorder—just from a photo of your hand.
Research suggests a bidirectional relationship between posttraumatic stress disorder and fibromyalgia in military service ...
Elderberry tea is made from dried elderberries and is rich in antioxidants with anti-inflammatory properties. Some research suggests it may help reduce the severity of colds, flu, and other ...
Stanford researchers develop breakthrough nasal spray vaccine that could potentially protect against a variety of infections, ...
New research explores if lymphovenous bypass surgery, typically used in plastic surgery, can treat Alzheimer's by flushing neurotoxins from the brain.
Full-year 2025 net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® (pegcetacoplan) full year 2025 net product revenue of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results